Oppenheimer Asset Management’s Phibro Animal Health PAHC Stock Holding History
Bought
Maintained
Sold
Other funds holding PAHC
FMI
HA
Oppenheimer Asset Management's PAHC Position: Q3 2021 in Review
Oppenheimer Asset Management sold out of Phibro Animal Health (PAHC) in Q3 2021, closing a stake of 13,893 shares — an estimated $401K sold.
Oppenheimer Asset Management first reported a position in PAHC in Q1 2017 and held it in 14 quarters. The position peaked at $577K in Q4 2019. 142 funds tracked by Wall St. Rank hold PAHC as of Q3 2021.
- Oppenheimer Asset Management reported no remaining Phibro Animal Health position as of Q3 2021 after selling out during the quarter.
- Oppenheimer Asset Management sold 13,893 Phibro Animal Health shares in Q3 2021, an estimated $401K.
- Oppenheimer Asset Management first reported a position in Phibro Animal Health in Q1 2017 and held it in 14 quarters.
- Oppenheimer Asset Management's Phibro Animal Health position peaked at $577K in Q4 2019.
- 142 funds tracked by Wall St. Rank held Phibro Animal Health as of Q3 2021.
Based on Oppenheimer Asset Management's 13F filing for Q3 2021, filed 12 Nov 2021.